Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Hemab ApS
APS
Active
CVR 40837590
Nordre Fasanvej 215, 2000
Frederiksberg
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2019 · 6 years old
42 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Hemab ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
No figures reported for this period.
EBITDA
DKK millions
0M
-50M
-100M
-150M
-200M
2021: -41M
-41M
2021
2022: -161M (-293% vs 2021)
-161M
-293%
2022
2023: -27M (+83% vs 2022)
-27M
+83%
2023
2024: -48M (-78% vs 2023)
-48M
-78%
2024
2025: -69M (-44% vs 2024)
-69M
-44%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
—
—
—
—
—
Staff expenses
-18.273
-10.663
-4.316
-17.655
-0
EBITDA
-68.768
-47.897
-27.069
-161.480
-41.156
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-68.768
-47.897
-27.069
-161.480
-41.156
Net financials
6.388
270
5.081
224
1.023
Profit before tax
-62.380
-47.627
-21.988
-161.256
-40.134
Tax
-1.027
585
795
-4.849
-4.971
Net profit
-61.353
-48.212
-22.783
-156.407
-35.163
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
195.363
96.902
139.476
32.916
78.696
Equity
183.422
88.354
136.196
6.101
68.035
Long-term debt
1.345
1.974
167
0
0
Short-term debt
10.596
6.574
3.113
26.815
10.661
Total debt
11.941
8.548
3.280
26.815
10.661
Financial ratios
5-year trend
EBITDA margin (of gross profit)
<−999 %
This company
2021
2025
Equity ratio
93,9 %
This company
38,2 %
Market median
This company
Market median
146% above market
2021
2025
Return on equity
-33,4 %
This company
18,4 %
Market median
This company
Market median
282% below market
2021
2025
Net profit margin (of gross profit)
<−999 %
This company
2021
2025
Asset turnover (of gross profit)
0,00×
This company
2021
2025
Debt / equity
0,07×
This company
0,62×
Market median
This company
Market median
89% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Hemab ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
